Funding Details
- Awarder
- Inbox
- Date Award
- January 06, 2020
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
-
$50,000,000
Company Info
- Founding Year
- 2011
- Traction
- Slayback's ANDA for Hydroxyprogesterone 5 ml vial was the first generic ANDA to be approved and launched in the U.S.
- Founders
- Ajay Singh
- Company Description
- Slayback Pharma believe every pharmaceutical product exhibits its own unique personality.
- Market
- Complex generic and specialty pharmaceutical products
- Location
-
Princeton,
New Jersey,
United States
- Coinvestors
- Everstone
Links